Vir Biotechnology Inc (NASDAQ: VIR) is -42.63% lower on its value in year-to-date trading and has touched a low of $4.32 and a high of $14.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VIR stock was last observed hovering at around $5.41 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $5.49, the stock is 2.43% and 6.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.28 million and changing 1.48% at the moment leaves the stock -24.35% off its SMA200. VIR registered -25.20% loss for a year compared to 6-month loss of -46.31%. The firm has a 50-day simple moving average (SMA 50) of $5.2075 and a 200-day simple moving average (SMA200) of $7.2864.
The stock witnessed a 4.77% gain in the last 1 month and extending the period to 3 months gives it a -2.31%, and is -7.42% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.54% over the week and 5.45% over the month.
Vir Biotechnology Inc (VIR) has around 408 employees, a market worth around $758.93M and $20.86M in sales. Profit margin for the company is -2769.04%. Distance from 52-week low is 27.08% and -62.01% from its 52-week high. The company has generated returns on investments over the last 12 months (-51.03%).
The EPS is expected to grow by 18.32% this year
329.0 institutions hold shares in Vir Biotechnology Inc (VIR), with institutional investors hold 88.41% of the company’s shares. The shares outstanding are 138.06M, and float is at 89.11M with Short Float at 12.59%. Institutions hold 79.05% of the Float.
The top institutional shareholder in the company is SB INVESTMENT ADVISERS (UK) LTD with over 16.68 million shares valued at $148.49 million. The investor’s holdings represent 12.2466 of the VIR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 16.43 million shares valued at $146.26 million to account for 12.0632 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 12.85 million shares representing 9.4317 and valued at over $114.36 million, while STATE STREET CORP holds 3.7398 of the shares totaling 5.09 million with a market value of $45.34 million.
Vir Biotechnology Inc (VIR) Insider Activity
The most recent transaction is an insider sale by Eisner Mark, the company’s EVP and Chief Medical Officer. SEC filings show that Eisner Mark sold 6,796 shares of the company’s common stock on Jul 15 ’25 at a price of $5.47 per share for a total of $37162.0. Following the sale, the insider now owns 0.11 million shares.
Vir Biotechnology Inc disclosed in a document filed with the SEC on Jul 17 ’25 that Eisner Mark (EVP and Chief Medical Officer) sold a total of 3,586 shares of the company’s common stock. The trade occurred on Jul 17 ’25 and was made at $5.47 per share for $19629.0. Following the transaction, the insider now directly holds 0.1 million shares of the VIR stock.
